The performance of semi-quantitative differential PCR is similar to that of real-time PCR for the detection of the MYCN gene in neuroblastomas

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 9, 2009, Pages 791-795

  Souza, A C M F ^a   Souza, D R V ^a   Sanabani, S S ^b   Giorgi, R R ^a   Bendit, I ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

Author keywords

Amplification; MYCN; Neuroblastoma; Real time PCR; Semi quantitative PCR

Indexed keywords

BIOLOGICAL MARKER; PROTEIN MYCN; UNCLASSIFIED DRUG;

ARTICLE; BRAZIL; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENE DUPLICATION; HUMAN; HUMAN TISSUE; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PERFORMANCE MEASUREMENT SYSTEM; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEMIQUANTITATIVE DIFFERENTIAL POLYMERASE CHAIN REACTION;

EID: 71049144017     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009000900004     Document Type: Article

References (13)

1. Howman-Giles R, Shaw PJ, Uren RF, Chung DK. Neuroblastoma and other neuroendocrine tumors. Semin Nucl Med 2007; 37: 286-302.
2. Brodeur GM. Molecular basis for heterogeneity in human neuroblastomas. Eur J Cancer 1995; 31A: 505-510.
3. Philip T. [Massive chemotherapy followed by autologous bone marrow transplantation in pediatric oncology: for or against?]. Bull Cancer 1995; 82: 3-5.
4. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313: 1111-1116. (Pubitemid 16216827)
5. Kohl NE, Gee CE, Alt FW. Activated expression of the N-myc gene in human neuroblastomas and related tumors. Science 1984; 226: 1335-1337. (Pubitemid 15215589)
6. Schwab M, Ellison J, Busch M, Rosenau W, Varmus HE, Bishop JM. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci U S A 1984; 81: 4940-4944. (Pubitemid 14066230)
7. Hiyama E, Hiyama K, Yokoyama T, Fukuba I, Yamaoka H, Shay JW, et al. Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma. Clin Cancer Res 1999; 5: 601-609. (Pubitemid 29131970)
8. De Preter K, Speleman F, Combaret V, Lunec J, Laureys G, Eussen BH, et al. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod Pathol 2002; 15: 159-166. (Pubitemid 34171326)
9. Tajiri T, Tanaka S, Shono K, Kinoshita Y, Fujii Y, Suita S, et al. Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma. Cancer Lett 2001; 166: 89-94. (Pubitemid 32274289)
10. Tanaka S, Tajiri T, Noguchi S, Shono K, Ihara K, Hara T, et al. Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma. J Pediatr Surg 2004; 39: 63-68. (Pubitemid 38049838)
11. Canete A, Gerrard M, Rubie H, Castel V, Di Cataldo A, Munzer C, et al. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience. J Clin Oncol 2009; 27: 1014-1019.
12. Gilbert J, Norris MD, Haber M, Kavallaris M, Marshall GM, Stewart BW. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction. Mol Cell Probes 1993; 7: 227-234. (Pubitemid 23232243)
13. Raggi CC, Bagnoni ML, Tonini GP, Maggi M, Vona G, Pinzani P, et al. Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the Taq-Man detection system. Clin Chem 1999; 45: 1918-1924. (Pubitemid 29521998)